NCT04633616 Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients Status COMPLETED Phase NA
NCT04603027 A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT04571567 A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT04555707 The Maintenance Effect of Enstilar Foam in Combination With Otezla Status UNKNOWN Phase PHASE4
NCT04535999 Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV) Status COMPLETED Phase PHASE4
NCT04533737 Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab Status TERMINATED Phase PHASE4
NCT04515732 Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP) Status UNKNOWN Phase PHASE4
NCT04513847 PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis Status COMPLETED Phase N/A
NCT04488185 An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound Status WITHDRAWN Phase PHASE4
NCT04469829 Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome Status UNKNOWN Phase PHASE4
NCT04459780 Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis Status COMPLETED Phase NA
NCT04439526 A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis Status COMPLETED Phase N/A